Prescription drug · ANDA
Potassium Chloride in Lactated Ringers and Dextrose NDC 65219-246
Potassium chloride 1.79 g/1000mL + 4 more ingredients · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65219-246-10 | 65219024610 | 10 BAG in 1 CASE (65219-246-10) / 1000 mL in 1 BAG (65219-246-00)Marketed from Nov 4, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Potassium Chloride in Lactated Ringers and Dextrose
- Generic name (nonproprietary)
- potassium chloride, sodium chloride, calcium chloride, sodium lactate, and dextrose monohydrate
- Active ingredients
- Potassium chloride — 1.79 g/1000mLSodium chloride — 6 g/1000mLCalcium chloride — .2 g/1000mLSodium lactate — 3.1 g/1000mLDextrose monohydrate — 50 g/1000mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Fresenius Kabi USA, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211428
- Marketing start
- Listing expires
- Other FDA classes
- Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 65219-246_74552771-ddb3-4227-8e89-421294d86653SPL ID 74552771-ddb3-4227-8e89-421294d86653SPL set ID dbed53b7-0109-4561-8342-0178ec8c64b0RxCUI 847626UNII 660YQ98I10, 451W47IQ8X, M4I0D6VV5M, TU7HW0W0QT, LX22YL083G
- Pharmacologic class
- Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N465219024610followed by a unit qualifier and the quantityPackage 65219-0246-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE This solution is indicated in patients requiring parenteral administration of potassium chloride and the replacement of extracellular losses of fluids and electrolytes with minimal carbohydrate calories.
Excerpt only. Read the full label for complete information.